Source material:

Highlights of the recently released WHA report.

FACTS about Necro-Mortosis:

Mortosis is transferable through the exchange of blood, saliva or other bodily fluids, including bites.

Mortosis can be contracted through sharing of needles. Virus can be sexually transmitted (if partner is infected)

There is no known antidote at this point (Beware internet scams claiming to sell cures or inhibitors)

Mortosis is NOT airborne

Only infected people will reanimate upon death.

None infected people or people who die of natural causes do NOT rise.

If bitten, (or otherwise infected) on an arm or leg, severing the affected appendage may remove the infection, but only within the first few minutes of exposure. Burning the affected wound will only act to cortorize the wound. Not remove the infection.

Animals exposed to the Necro-Mortosis virus will become sick and die but do not reanimate. Livestock exposed must be destroyed.


Upon infection, the exposed usually succumbs to reanimation within 4 - 48 hours. First stage symptoms feel like flu. Migraine, hot flushes, aching muscles.

Second stage is followed by severe chills, extreme lethargy, some disorientation, and a gradual slowing of the heart rate. At this point, many fall into coma or suffer stroke or heart failure. This is due to the massive shock to the bodies immune system. Necrosis and mortification follow soon afterwards.

Reanimation can occur within minutes. Studied subjects have nearly always reanimated within the first hour of death.

Studying The Undead
ZWN Exclusive interview with Yale Psychologist Dr. Maria Perez
By ZWN Field reporter -
Ruth Ellis Haworth

Read Report:

This site is for entertainment purposes only. All stories and events are fictional. Any similarities with persons either living or deceased in purely coincidental. There is occasional satirizing of prominent world leaders. Contents of this site are copyrighted. All rights reserved.
Bookmark and Share

Index of Other Major Non-Related Diseases & Conditions

Asthma & Allergies
Avian Influenza
Birth Defects
Chronic Fatigue Syndrome
E. coli
Fetal Alcohol Syndrome
Flu (Influenza)
Genital Herpes (Herpes Simplex Virus)
Heart Disease
HPV (Human papillomavirus)
Norovirus Infection
Sexually Transmitted Diseases
Trichomonas Infection (Trichomoniasis)
Tuberculosis (TB)

Main Content Source: Centers for Disease Control and Prevention

Amcalon Tests Vaccine
XL-6 Inhibitor.

California, USA
Posted: 5th, July. 2009


Southern California based Amcalon released a short press statement on it's website today. The pharmaceutical giant announced that it had reached 'Phase four' in it's struggle to get the much anticipated 'XL-6 Inhibitor' drug into test markets.

Amcalon's road to launching this potential vaccine has been hampered by Government red tape, protracted FDA approval, and two administrations wildly differing views on stem cell research. ZWN's Science Editor Dr. Nancy Chan says "This is a hugely significant step forward. 'Phase four' is, according to FDA guidelines, a phase of post-approval surveillance. Post-marketing surveillance maintaines the safety of a drug in closely monitored test patient groups."

The whereabouts of all six test markets are a closely guarded secret at this time.

The only other significant contender in the potentially huge market of Necro-Mortosis vaccination is ImClonex Systems (nasdaq: IMCLX). However, they two are significantly hampered by the protracted legal process involved in bringing their own inhibitor - Ibrex to market.

Nasdaq rallied on good news from Amcalon's Phase IV trial for Mortosis vaccination. Shares of Amcalon were up 11.7%, or $9.65 to $103.56. However, ImClonex Systems (nasdaq: IMCLX) drug Ibrex, took a loss and was down off $4.52, or 3.9%, to $38.63

Necrosis research to resume.
Washington, DC - USA
Posted: 9th, Mar. 2009

President Obama signed an executive order Monday overturning a Bush-era policy that limited federal tax dollars for embryonic stem cell research.

Read full report

Related report:
New drug hope
Stem cell ban
Stem cell hope

Silke Koch
Neus Vargas
- recovery

Neus Vargas - Death

Middle East
South Asia
Zombie Hunters
The Human Race
Dead Center
ZWN Field Reports
Contact Us
About ZWN
There are strict guidelines in the disposing of a corpse. Do not bury, burn or otherwise dispose of any deceased person. You are required by law to call your local authorities for collection and quarantine. The government has released a help number
1 800 155 1216
The slow decline of a
Necro-Mortosis sufferer.

Part One

Part Two
Medical breakthrough - Hope found In new drug
Read report
Stem Cell research ban hampers XL6 development Read report
Unlocking the code - How the virus works Read Report
Fact Sheet For Health Professionals

Emergency Wound Management for Healthcare Professionals in the treatment of Necro-Mortosis victims

The risk for injury to both citizens and Healthcare Professionals during and after an undead outbreak is high. Apart from Necro-Mortosis contamination from bites, other problems such as blunt force trauma wounds mental trauma and tetanus have to be contended with. Tetnus is a potential health threat for persons who sustain wound injuries. Tetanus is a serious, often fatal, toxic condition, but is virtually 100% preventable with vaccination. Any wound has the potential for becoming infected with either mortosis and/or tetnus, and should be assessed by a health-care provider as soon as possible.

These principles can assist with wound management and aid in the prevention of amputations. In the wake of a 'Level three' undead outbreak resources are limited. Following these basic wound management steps can help prevent further medical problems.

Ensure that the scene is safe for you to approach the patient, and that if necessary; it is secured by the proper authorities (police, fire, civil defense) prior to patient evaluation.
Observe universal precautions, when possible, while participating in all aspects of wound care.
Obtain a focused history from the patient, and perform an appropriate examination to exclude additional injuries.

Apply direct pressure to any bleeding wound, to control hemorrhage.
Tourniquets are rarely indicated since they may reduce tissue viability.
Examine wounds for gross contamination, devitalized tissue, and foreign bodies.

Remove constricting rings or other jewelry from injured body part.
Cleanse the wound periphery with soap and sterile water or available solutions, and provide anesthetics and analgesia whenever possible.
Irrigate wounds with saline solution using a large bore needle and syringe. If unavailable, bottled water is acceptable.

Leave contaminated wounds, bites, and punctures open. Wounds that are sutured in an un sterile environment, or are not cleansed, irrigated, and debrided appropriately, are at high risk for infection due to contamination. Wounds that are not closed primarily because of high risk of infection should be considered for delayed primary closure by experienced medical staff using sterile technique.

Remove devitalized tissue and foreign bodies prior to repair as they may increase the incidence of infection.

Clip hair close to the wound, if necessary. Shaving of hair is not necessary, and may increase the chance of wound infection.

Cover wounds with dry dressing; deeper wounds may require packing with saline soaked gauze and subsequent coverage with a dry bulky dressing.

If wound infections develop, and patient shows early to mid signs of mortosis, such as a lowering of temperature, aggressive behavior, confusion, flu symptoms. migraine, hot flushes, aching muscles or a slowing of the heart rate, patient must be secured, tagged, and admitted to quarantine immediately.

Other Considerations
Be vigilant for the presence of other injuries in patients with any wounds.
Ensure adequate referral, follow-ups, and reevaluations whenever possible.
Dirty water and soil and sand can cause infection. Wounds can become contaminated by even very tiny amounts of dirt.

Puncture wounds can carry bits of clothing and debris into wound resulting in infection.

Crush injuries are more susceptible to infection than wounds from shearing forces.

Guidance for Management of Wound Infections
Most wound infections are due to staphylococci and streptococci. This would likely hold true even in an undead outbreak situation.

For initial antimicrobial treatment of infected wounds, beta-lactam antibiotics with anti-staphylococcal activity (cephalexin, dicloxacillin, ampicillin/sulbactam etc.) and clindamycin are recommended options.
Of note, recently an increasing number of community associated skin and soft tissue infections appear to be caused by methicillin-resistant Staphylococcus aureus (MRSA). Infections caused by this organism will not respond to treatment with beta-lactam antibiotics and should be considered in patients who fail to respond to this therapy. Treatment options for these community MRSA infections include trimethoprim-sulfamethoxazole (oral) or vancomycin (intravenous). Clindamycin is also a potential option, but not all isolates are susceptible.
Incision and drainage of any subcutaneous collections of pus (abscesses) is also an important component of treating wound infections.

Partial sources:
6th Edi
tion Emergency Medicine: A Comprehensive Study Guide, 2004
2nd Edition. Sanitation and the undead, 2007
34 th Edition.The Sanford Guide to Antimicrobial Therapy, 2004,
2nd Edition Treatment of the Undead. Necro-Mortosis 2006

How the virus works - The challenge ahead
What are the different levels of a Necro-Mortosis outbreak?
Mortosis outbreak Categories
Mortosis outbreaks can be separated into three categories, depending on how easily they can can spread and the severity of death they cause. Category A outbreaks are considered the highest risk and Category C outbreaks are those that are considered emerging threats or easily containable.

Category Level 'A'
These high-priority outbreaks pose the highest risk to the public and national security because:

They can be easily spread or transmitted from person to person
They result in high death rates and have the potential for major public health impact
They might cause public panic and social disruption
They require special action for public health preparedness.

Category Level 'B'
These outbreaks are the second highest priority because:

They are moderately easy to spread
They result in a moderate rate of death and/or low death rates
They require specific enhancements of Center for Disease Control's laboratory capacity and enhanced disease monitoring.

Category Level 'C'
These third highest priority outbreaks include emerging threats that could be spread in the future because:

They are easily transferable
They have potential for high morbidity and mortality rates and major health impact.

Source: CDC - Center for Disease Control and Prevention